Advertisement

Ads Placeholder
Loading...

Yunkang Group Limited

2325.HKHKSE
Healthcare
Medical - Diagnostics & Research
HK$0.83
HK$0.03(3.75%)
Hong Kong Market opens in 38h 2m

Yunkang Group Limited Fundamental Analysis

Yunkang Group Limited (2325.HK) shows weak financial fundamentals with a PE ratio of -1.10, profit margin of -80.99%, and ROE of -34.90%. The company generates $0.5B in annual revenue with weak year-over-year growth of -20.15%.

Key Strengths

Cash Position348.11%
PEG Ratio-0.23

Areas of Concern

ROE-34.90%
Operating Margin-75.66%
We analyze 2325.HK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -97.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-97.6/100

We analyze 2325.HK's fundamental strength across five key dimensions:

Efficiency Score

Weak

2325.HK struggles to generate sufficient returns from assets.

ROA > 10%
-12.68%

Valuation Score

Excellent

2325.HK trades at attractive valuation levels.

PE < 25
-1.10
PEG Ratio < 2
-0.23

Growth Score

Weak

2325.HK faces weak or negative growth trends.

Revenue Growth > 5%
-20.15%
EPS Growth > 10%
-7.47%

Financial Health Score

Excellent

2325.HK maintains a strong and stable balance sheet.

Debt/Equity < 1
0.93
Current Ratio > 1
1.45

Profitability Score

Weak

2325.HK struggles to sustain strong margins.

ROE > 15%
-3490.07%
Net Margin ≥ 15%
-80.99%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is 2325.HK Expensive or Cheap?

P/E Ratio

2325.HK trades at -1.10 times earnings. This suggests potential undervaluation.

-1.10

PEG Ratio

When adjusting for growth, 2325.HK's PEG of -0.23 indicates potential undervaluation.

-0.23

Price to Book

The market values Yunkang Group Limited at 0.39 times its book value. This may indicate undervaluation.

0.39

EV/EBITDA

Enterprise value stands at -3.86 times EBITDA. This is generally considered low.

-3.86

How Well Does 2325.HK Make Money?

Net Profit Margin

For every $100 in sales, Yunkang Group Limited keeps $-80.99 as profit after all expenses.

-80.99%

Operating Margin

Core operations generate -75.66 in profit for every $100 in revenue, before interest and taxes.

-75.66%

ROE

Management delivers $-34.90 in profit for every $100 of shareholder equity.

-34.90%

ROA

Yunkang Group Limited generates $-12.68 in profit for every $100 in assets, demonstrating efficient asset deployment.

-12.68%

Following the Money - Real Cash Generation

Operating Cash Flow

Yunkang Group Limited produces operating cash flow of $85.62M, showing steady but balanced cash generation.

$85.62M

Free Cash Flow

Yunkang Group Limited generates strong free cash flow of $80.74M, providing ample flexibility for dividends, buybacks, or growth.

$80.74M

FCF Per Share

Each share generates $0.14 in free cash annually.

$0.14

FCF Yield

2325.HK converts 18.93% of its market value into free cash.

18.93%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.10

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.23

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.39

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.89

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.93

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.45

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.35

vs 25 benchmark

ROA

Return on assets percentage

-0.13

vs 25 benchmark

ROCE

Return on capital employed

-0.27

vs 25 benchmark

How 2325.HK Stacks Against Its Sector Peers

Metric2325.HK ValueSector AveragePerformance
P/E Ratio-1.1028.45 Better (Cheaper)
ROE-34.90%763.00% Weak
Net Margin-80.99%-45265.00% (disorted) Weak
Debt/Equity0.930.34 Weak (High Leverage)
Current Ratio1.452795.60 Neutral
ROA-12.68%-16588.00% (disorted) Weak

2325.HK outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Yunkang Group Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

8.21%

Industry Style: Defensive, Growth, Innovation

Growing

EPS CAGR

-2534.99%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

3393.25%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ